Molina Healthcare (NYSE:MOH) Given New $128.00 Price Target at Morgan Stanley

Molina Healthcare (NYSE:MOH) had its target price cut by Morgan Stanley from $158.00 to $128.00 in a report published on Wednesday morning,Benzinga reports. They currently have an equal weight rating on the stock.

A number of other research firms have also recently commented on MOH. Wells Fargo & Company set a $141.00 target price on shares of Molina Healthcare and gave the company an “equal weight” rating in a research report on Friday, February 20th. Jefferies Financial Group set a $160.00 price target on Molina Healthcare in a research report on Tuesday, December 16th. The Goldman Sachs Group decreased their price objective on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a report on Wednesday, February 11th. Truist Financial dropped their target price on Molina Healthcare from $190.00 to $145.00 and set a “hold” rating on the stock in a research note on Tuesday, February 17th. Finally, Mizuho set a $220.00 target price on Molina Healthcare in a research report on Friday, January 9th. Two equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $155.71.

Molina Healthcare Price Performance

Shares of MOH stock opened at $150.08 on Wednesday. The stock’s 50-day moving average is $166.95 and its 200 day moving average is $168.43. Molina Healthcare has a 1-year low of $121.06 and a 1-year high of $359.97. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.69 and a quick ratio of 1.69. The company has a market cap of $7.73 billion, a P/E ratio of 17.53 and a beta of 0.52.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. The firm had revenue of $11.38 billion for the quarter, compared to analysts’ expectations of $10.90 billion. During the same period in the previous year, the company posted $5.05 earnings per share. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Research analysts predict that Molina Healthcare will post 24.4 earnings per share for the current fiscal year.

Institutional Trading of Molina Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Torren Management LLC purchased a new stake in Molina Healthcare during the 4th quarter valued at about $26,000. Miller Global Investments LLC acquired a new stake in shares of Molina Healthcare during the fourth quarter worth about $27,000. Cromwell Holdings LLC lifted its holdings in shares of Molina Healthcare by 211.9% during the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after purchasing an additional 125 shares during the period. Quarry LP purchased a new stake in Molina Healthcare in the fourth quarter valued at approximately $32,000. Finally, First Horizon Advisors Inc. increased its holdings in Molina Healthcare by 2,140.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 112 shares of the company’s stock worth $33,000 after buying an additional 107 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.